Literature DB >> 19764077

CHM gene molecular analysis and X-chromosome inactivation pattern determination in two families with choroideremia.

Hector J Perez-Cano1, Rosa E Garnica-Hayashi, Juan C Zenteno.   

Abstract

Choroideremia is an X-linked recessive retinal dystrophy characterized by progressive loss of the photoreceptor, the retinal pigment epithelium, and the choriocapillaris layers which ultimately can result in blindness by the fifth decade of life. The disease is caused by mutations in the gene CHM, which encodes a protein involved in the regulation of intracellular vesicular traffic. Typically, hemizygous males are affected by the disease and female carriers are asymptomatic with only a diffuse mottled pattern of hyperpigmentation on funduscopy. Uncommon instances of fully affected females have been described previously and these cases are proposed to arise from an skewed Lyonization mechanism preferentially inactivating the X chromosome carrying the normal CHM allele. In this work, the clinical and molecular features of two Mexican families with choroideremia are described. A novel and a previously described CHM mutation were identified. X-chromosome inactivation assays were performed in a total of 12 heterozygous carriers from the two families. In an affected female from family A, a random X-inactivation pattern was demonstrated; on the other hand, in a female carrier from family B displaying a conspicuous pattern of pigment epithelium mottling at the peripheral retina, a skewed X-inactivation pattern was found. However, the X-chromosome preferentially inactivated in this female was the one carrying the mutated allele. Our results add to the genotypic spectrum in choroideremia and does not support a correlation between X-inactivation status and abnormal retinal phenotype in heterozygous female carriers from these two families.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19764077     DOI: 10.1002/ajmg.a.32727

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  The Role of X-Chromosome Inactivation in Retinal Development and Disease.

Authors:  Abigail T Fahim; Stephen P Daiger
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  Identification of the genetic determinants responsible for retinal degeneration in families of Mexican descent.

Authors:  Adda Villanueva; Pooja Biswas; Kameron Kishaba; John Suk; Keerti Tadimeti; Pongali B Raghavendra; Karine Nadeau; Bruno Lamontagne; Lambert Busque; Steve Geoffroy; Ian Mongrain; Géraldine Asselin; Sylvie Provost; Marie-Pierre Dubé; Eric Nudleman; Radha Ayyagari
Journal:  Ophthalmic Genet       Date:  2017-09-25       Impact factor: 1.803

3.  Spectrum of Disease Severity and Phenotype in Choroideremia Carriers.

Authors:  Ruben Jauregui; Karen Sophia Park; Akemi J Tanaka; Ahra Cho; Maarjaliis Paavo; Jana Zernant; Jasmine H Francis; Rando Allikmets; Janet R Sparrow; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2019-06-08       Impact factor: 5.258

4.  CHOROIDEREMIA: Retinal Degeneration With an Unmet Need.

Authors:  Mark E Pennesi; David G Birch; Jacque L Duncan; Jean Bennett; Aniz Girach
Journal:  Retina       Date:  2019-11       Impact factor: 4.256

5.  Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation.

Authors:  Alex S Huang; Leo A Kim; Amani A Fawzi
Journal:  Arch Ophthalmol       Date:  2012-09

6.  Molecular analysis of the choroideremia gene related clinical findings in two families with choroideremia.

Authors:  Ying Lin; Xialin Liu; Lixia Luo; Bo Qu; Shuhong Jiang; Huiqin Yang; Xuanwei Liang; Shaobi Ye; Yizhi Liu
Journal:  Mol Vis       Date:  2011-09-30       Impact factor: 2.367

7.  Novel CHM mutations in Polish patients with choroideremia - an orphan disease with close perspective of treatment.

Authors:  Anna Skorczyk-Werner; Anna Wawrocka; Natalia Kochalska; Maciej Robert Krawczynski
Journal:  Orphanet J Rare Dis       Date:  2018-12-12       Impact factor: 4.123

8.  Pathogenic mechanisms and the prospect of gene therapy for choroideremia.

Authors:  Ioannis S Dimopoulos; Stephanie Chan; Robert E MacLaren; Ian M MacDonald
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-01       Impact factor: 0.694

9.  AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models.

Authors:  Vidyullatha Vasireddy; Jason A Mills; Rajashekhar Gaddameedi; Etiena Basner-Tschakarjan; Monika Kohnke; Aaron D Black; Krill Alexandrov; Shangzhen Zhou; Albert M Maguire; Daniel C Chung; Helen Mac; Lisa Sullivan; Paul Gadue; Jeannette L Bennicelli; Deborah L French; Jean Bennett
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

10.  Next-generation sequencing-based clinical diagnosis of choroideremia and comprehensive mutational and clinical analyses.

Authors:  Feng-Juan Gao; Guo-Hong Tian; Fang-Yuan Hu; Dan-Dan Wang; Jian-Kang Li; Qing Chang; Fang Chen; Ge-Zhi Xu; Wei Liu; Ji-Hong Wu
Journal:  BMC Ophthalmol       Date:  2020-06-01       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.